bluebird bio, Inc. (BLUE)
Jun 2, 2025 - BLUE was delisted (reason: acquired by Carlyle and SK Capital)
4.970
0.00 (0.00%)
Inactive · Last trade price on May 30, 2025

bluebird bio Revenue

bluebird bio had revenue of $38.71M in the quarter ending March 31, 2025, with 108.43% growth. This brings the company's revenue in the last twelve months to $103.95M, up 127.51% year-over-year. In the year 2024, bluebird bio had annual revenue of $83.81M with 184.12% growth.

Revenue (ttm)
$103.95M
Revenue Growth
+127.51%
P/S Ratio
0.46
Revenue / Employee
$419,137
Employees
248
Market Cap
48.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202483.81M54.31M184.12%
Dec 31, 202329.50M25.90M720.04%
Dec 31, 20223.60M-65.00K-1.77%
Dec 31, 20213.66M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition